GenSight Biologics Market Cap

GenSight Biologics has a market cap or net worth of €20.46 million as of March 6, 2026. Its market cap has decreased by -35.21% in one year.

Market Cap

20.46M

Enterprise Value

39.20M

Revenue

945.00K

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.09

Market Cap Chart

Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 20.46M, a decrease of -91.88%. That is a compound annual growth rate of -22.92%.

Market Cap History

Date	Market Cap	% Change
Mar 5, 2026	20.46M	-11.11%
Dec 31, 2025	23.02M	-30.35%
Dec 31, 2024	33.05M	28.79%
Dec 29, 2023	25.66M	-83.46%
Dec 30, 2022	155.20M	-39.23%
Dec 31, 2021	255.38M	-16.09%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
genOway Société anonyme	21.58M
Aelis Farma	17.26M
Advicenne	27.63M
NFL Biosciences	13.58M
Poxel	13.30M
Oncodesign Precision Medicine Société anonyme	11.56M
Fermentalg	38.22M
Nicox	39.84M

Market Cap Rankings